TY - JOUR
T1 - Prevention and management of osteoporosis and osteoporotic fractures in persons with a spinal cord injury or disorder
T2 - A systematic scoping review
AU - Zleik, Nour
AU - Weaver, Frances
AU - Harmon, Robert L.
AU - Le, Brian
AU - Radhakrishnan, Reshmitha
AU - Jirau-Rosaly, Wanda D.
AU - Craven, B. Catharine
AU - Raiford, Mattie
AU - Hill, Jennifer N.
AU - Etingen, Bella
AU - Guihan, Marylou
AU - Heggeness, Michael H.
AU - Ray, Cara
AU - Carbone, Laura
N1 - Publisher Copyright:
© 2018, © The Academy of Spinal Cord Injury Professionals, Inc. 2018.
PY - 2019/11/2
Y1 - 2019/11/2
N2 - Objectives: The primary objective was to review the literature regarding methodologies to assess fracture risk, to prevent and treat osteoporosis and to manage osteoporotic fractures in SCI/D. Study Design: Scoping review. Settings/Participants: Human adult subjects with a SCI/D. Outcome measures: Strategies to identify persons with SCI/D at risk for osteoporotic fractures, nonpharmacological and pharmacological therapies for osteoporosis and management of appendicular fractures. Results: 226 articles were included in the scoping review. Risk of osteoporotic fractures in SCI is predicted by a combination of DXA-defined low BMD plus clinical and demographic characteristics. Screening for secondary causes of osteoporosis, in particular hyperparathyroidism, hyperthyroidism, vitamin D insufficiency and hypogonadism, should be considered. Current antiresorptive therapies for treatment of osteoporosis have limited efficacy. Use of surgery to treat fractures has increased and outcomes are good and comparable to conservative treatment in most cases. A common adverse event following fracture was delayed healing. Conclusions: Most of the research in this area is limited by small sample sizes, weak study designs, and significant variation in populations studied. Future research needs to address cohort definition and study design issues.
AB - Objectives: The primary objective was to review the literature regarding methodologies to assess fracture risk, to prevent and treat osteoporosis and to manage osteoporotic fractures in SCI/D. Study Design: Scoping review. Settings/Participants: Human adult subjects with a SCI/D. Outcome measures: Strategies to identify persons with SCI/D at risk for osteoporotic fractures, nonpharmacological and pharmacological therapies for osteoporosis and management of appendicular fractures. Results: 226 articles were included in the scoping review. Risk of osteoporotic fractures in SCI is predicted by a combination of DXA-defined low BMD plus clinical and demographic characteristics. Screening for secondary causes of osteoporosis, in particular hyperparathyroidism, hyperthyroidism, vitamin D insufficiency and hypogonadism, should be considered. Current antiresorptive therapies for treatment of osteoporosis have limited efficacy. Use of surgery to treat fractures has increased and outcomes are good and comparable to conservative treatment in most cases. A common adverse event following fracture was delayed healing. Conclusions: Most of the research in this area is limited by small sample sizes, weak study designs, and significant variation in populations studied. Future research needs to address cohort definition and study design issues.
KW - Fracture
KW - Osteoporosis
KW - Spinal cord injury
UR - http://www.scopus.com/inward/record.url?scp=85046763416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046763416&partnerID=8YFLogxK
U2 - 10.1080/10790268.2018.1469808
DO - 10.1080/10790268.2018.1469808
M3 - Article
C2 - 29745791
AN - SCOPUS:85046763416
SN - 1079-0268
VL - 42
SP - 735
EP - 759
JO - Journal of Spinal Cord Medicine
JF - Journal of Spinal Cord Medicine
IS - 6
ER -